T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T

Table 2 Metrics of left ventricular function from standard CMR

	Healthy Control N = 20	DMD N = 28	p-Value	DMD LGE− N = 17	p-value	DMD LGE + N =9	p-Value
LVEF (%)	55.9 (5.8)	49.5 (11.3)	0.003	55.2 (10.9)^#	0.20	44.8 (10.7)	< 0.001
LVEDVI (ml/m²)	87.7 (15.2)	82.8 (27.9)	0.10	68.2 (26.8)^#	0.02	91.8 (39.6)	0.81
LVESVI (ml/m²)	38.5 (8.5)	38.7 (14.5)	0.89	36.4 (9.7)^#	0.02	45.5 (28.7)	0.03
LVMI (g/m²)	38.4 (7.8)	35.6 (9.8)	0.04	32.4 (8.4)	0.02	39.5 (8.7)	0.94

All subgroups compared to healthy controls. p-value ≤ 0.05 is significant
LVEF, left ventricular ejection fraction; LVEDVI left ventricular end-diastolic volume; LVESVI left ventricular end-systolic volume; LVMI left ventricular mass index; LGE-, late gadolinium enhancement negative; LGE+, late gadolinium enhancement positive
^#p ≤ 0.05 comparison between LGE − and LGE + boys

ISSN: 1532-429X